http://crossfitalpha1athlete.com/staff/matt-myers/ UK pharmacy valuations have been on the rise driven by significantly more demand than supply for pharmacy acquisitions. The UK…
Global Medtech deal volumes have fluctuated year on year since 2006 however recently there have been signs of change. Deal…
Following Allergan’s announcement on 13 February of its acquisition of bodycountouring specialist ZELTIQ for $2.7bn, investors have perked up. ZELTIQ’s…